nach oben

Acta Diabetologica

Erschienen in:

01.06.2009 | Original Article

Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats

verfasst von: Liping Zhang, Yaping Liu, Dong Wang, Xinbo Zhao, Zhanjun Qiu, Hong Ji, Haiqin Rong

Erschienen in: Acta Diabetologica | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

This study was performed to characterize the bone metabolism in ten 6-month-old male Goto-Kakizaki (GK) rats, a spontaneous type 2 diabetic model, with ten age- and sex-matched non-diabetic Wistar rats as controls. The femora and the fifth lumbar vertebrae were analyzed by a dual energy X-ray absorptiometry for bone mineral density. Histomorphometrical analyses were performed on the sections from the tibia embedded in methylmethacrylate. Biomechanical characterizations were made by a three-point bending test and a compressive test on the femur and the fifth vertebral body respectively. Compared to the control rats, the bone mineral density was significantly deceased and the histomorphometrical studies showed significantly decreased trabecular bone volume, trabecular thickness and number, osteoid surface and thickness, mineralizing surface, mineral apposition rate and bone formation rate, and also a significant increase in mineralization lag time in the diabetic rats. Strength in both bones and elastic modulus of vertebral body significantly decreased in the diabetic rats as well. In addition, the serum osteocalcin levels were significantly decreased and the serum tartrate-resistant acid phosphatase activity was significantly increased. In conclusion, the 6-month-old GK diabetic rats developed osteopenia with an increased risk of fracture owing to the decreased bone formation, and might be a useful model for unraveling the effects of diabetes on bones independent of obesity frequently seen in the type 2 diabetic patients.

Albright F, Reifenstein E (1948) Parathyroid glands and metabolic bone disease: selected studies. Williams and Wilkins, Baltimore

Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, Requena ME, Diosdado MA (2001) Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 7:346–351PubMed

Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR (1993) Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118:657–665PubMed

Tuominen JT, Impivaara O, Puukka P, Ronnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200PubMedCrossRef

Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD (2003) Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18:784–790PubMedCrossRef

Albala C, Yanez M, Devoto E, Sostin C, Zeballos L, Santos JL (1996) Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 20:1027–1032PubMed

Ahmad T, Ohlsson C, Saaf M, Ostenson CG, Kreicbergs A (2003) Skeletal changes in type-2 diabetic Goto-Kakizaki rats. J Endocrinol 178:111–116PubMedCrossRef

Östenson CG (2001) The Goto-Kakizaki rat. In: Sima A, Shafrir E (eds) Animal models in diabetes: a primer (Frontiers in Animal Diabetes Research). Harwood Academic Publishers, Amsterdam, pp 197–211

Xu J, Rong HQ, Ji H, Wang D, Liu CY (2006) Effects of human parathyroid hormone related protein on osteoporosis of variectomized rats. Chin J Rheumatol 10:154–157

10.

Catala-Gregori P, Garcia V, Hernandez F, Madrid J, Ceron JJ (2006) Response of broilers to feeding low-calcium and phosphorus diets plus phytase under different environmental conditions: body weight and tibiotarsus mineralization. Poult Sci 85:1923–1931PubMed

11.

Mattila P, Knuuttila M, Kovanen V, Svanberg M (1999) Improved bone biomechanical properties in rats after oral xylitol administration. Calcif Tissue Int 64:340–344PubMedCrossRef

12.

Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595–608PubMedCrossRef

13.

Erben RG (1997) Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45:307–313PubMed

14.

Miyakoshi N, Sato K, Abe T, Tsuchida T, Tamura Y, Kudo T (1999) Histomorphometric evaluation of the effects of ovariectomy on bone turnover in rat caudal vertebrae. Calcif Tissue Int 64:318–324PubMedCrossRef

15.

Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef

16.

Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424PubMedCrossRef

17.

Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N (2006) Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84:93–101PubMedCrossRef

18.

Verhaeghe J, Suiker AM, Visser WJ, Van Herck E, Van Bree R, Bouillon R (1992) The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134:485–492PubMedCrossRef

19.

Ahmad T, Ugarph-Morawski A, Lewitt MS, Li J, Saaf M, Brismar K (2008) Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat. Growth Horm IGF Res 18:404–411PubMedCrossRef

20.

Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef

21.

Portha B (2005) Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21:495–504PubMedCrossRef

22.

Augat P, Reeb H, Claes LE (1996) Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell. J Bone Miner Res 11:1356–1363PubMed

23.

Fuse H, Fukumoto S, Sone H, Miyata Y, Saito T, Nakayama K, Takahashi H, Matsumoto T, Ogata E (1997) A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats. J Bone Miner Res 12:590–597PubMedCrossRef

24.

Kanter M, Altan MF, Donmez S, Ocakci A, Kartal ME (2007) The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct 25:747–752PubMedCrossRef

25.

Verhaeghe J, Suiker AM, Einhorn TA, Geusens P, Visser WJ, Van Herck E, Van Bree R, Magitsky S, Bouillon R (1994) Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. J Bone Miner Res 9:1657–1667PubMed

26.

Ortoft G, Oxlund H (1988) Reduced strength of rat cortical bone after glucocorticoid treatment. Calcif Tissue Int 43:376–382PubMedCrossRef

27.

(2000 March 27–29) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17:1–36

28.

Ostenson CG, Fiere V, Ahmed M, Lindstrom P, Brismar K, Brismar T, Kreicbergs A (1997) Decreased cortical bone thickness in spontaneously non-insulin-dependent diabetic GK rats. J Diabetes Complications 11:319–322PubMedCrossRef

29.

Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM (2006) Bone mineral density and its determinants in diabetes: the fremantle diabetes study. Diabetologia 49:863–871PubMedCrossRef

30.

Perez-Castrillon JL, De Luis D, Martin-Escudero JC, Asensio T, del Amo R, Izaola O (2004) Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complicat 18:317–321PubMedCrossRef

31.

Bouillon R (1991) Diabetic bone disease. Calcif Tissue Int 49:155–160PubMedCrossRef

32.

Lee AJ, Hodges S, Eastell R (2000) Measurement of osteocalcin. Ann Clin Biochem 37:432–446PubMedCrossRef

33.

Amir G, Rosenmann E, Sherman Y, Greenfeld Z, Ne’eman Z, Cohen AM (2002) Osteoporosis in the Cohen diabetic rat: correlation between histomorphometric changes in bone and microangiopathy. Lab Invest 82:1399–1405PubMed

34.

Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, Graves DT (2006) Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 85:510–514PubMedCrossRef

35.

Burkemper KM, Garris DR (2006) Influences of obese (ob/ob) and diabetes (db/db) genotype mutations on lumber vertebral radiological and morphometric indices: skeletal deformation associated with dysregulated systemic glucometabolism. BMC Musculoskelet Disord 7:10PubMedCrossRef

36.

Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T (2006) Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc 98:1598–1604PubMed

37.

Cutrim DM, Pereira FA, de Paula FJ, Foss MC (2007) Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Braz J Med Biol Res 40:221–227PubMed

38.

Williams JP, Blair HC, McDonald JM, McKenna MA, Jordan SE, Williford J, Hardy RW (1997) Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun 235:646–651PubMedCrossRef

39.

Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954–959PubMedCrossRef

40.

Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270PubMed

Titel: Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats
verfasst von: Liping Zhang
Yaping Liu
Dong Wang
Xinbo Zhao
Zhanjun Qiu
Hong Ji
Haiqin Rong
Publikationsdatum: 01.06.2009
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 2/2009
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-008-0068-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

Cardiometabolic risk and educational level in adult patients with type 1 diabetes

Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels

Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes?

Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus